-

VySpine Announces Agreement with Oxford Performance Materials to Develop Unique Spinal Implants

TALLAHASSEE, Fla.--(BUSINESS WIRE)--VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has entered into a partnership agreement with Oxford Performance Materials (OPM), an industry leader in advanced polymer science and 3D printed orthopedic devices.

The agreement enables VySpine and OPM to collaboratively develop differentiated spine fusion products using OPM’s patented OsteoFab PEKK technology. VySpine is the designer of the OsteoVy PEKK lattice, which will be manufactured exclusively by OPM for VySpine.

“OPM is the ideal partner given its long history with the high performing thermoplastic PEKK and its experience with 3D printing of these materials,” said Tom McLeer, CEO of VySpine. “The OsteoVy PEKK polymer lattice structure is uniquely designed to promote bone integration. PEKK, unlike other orthopedic polymers, has demonstrated bony apposition performance, allowing for bone growth onto, and throughout, the OsteoVy PEKK lattice. OPM will be producing the OsteoVy PEKK lattice exclusively for VySpine.”

"We are delighted to be making this important announcement with VySpine,” said OPM founder & CEO Scott DeFelice. “OPM has a history of developing industry partnerships with companies dedicated to innovative solutions that push medical device technology forward in ways that improve patient outcomes. VySpine clearly fits that mold.”

About VySpine

VySpine was created through active internal development and the licensing of various proven technologies using innovative materials and designs. The company strives to outpace the competition by collaborating with key spine innovators while providing a flexible, cost-effective approach to spine care. Learn more at vyspine.com

About Oxford Performance Materials, Inc.

Oxford Performance Materials, Inc. was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM’s Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK brand, including coating technologies for a range of industrial and biomedical applications. The Company is a pioneer in 3D printing. OPM’s OsteoFab technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices, and OPM’s OXFAB production parts are designed for highly demanding industrial applications.

“VySpine” and “OsteoVy” are registered trademarks of VySpine.

“OsteoFab,” “OXFAB” and “OXPEKK” are registered trademarks of Oxford Performance Materials.

Contacts

OPM Contact: Vincent DeFelice, 413/552-8304, vdefelice@oxfordpm.com
VySpine Contact: Paul Williams, 310/569-0023, paul@medialinecommunications.com

VySpine


Release Versions

Contacts

OPM Contact: Vincent DeFelice, 413/552-8304, vdefelice@oxfordpm.com
VySpine Contact: Paul Williams, 310/569-0023, paul@medialinecommunications.com

More News From VySpine

Vy Spine Announces FDA Clearance for VyBrate VBR System

BOUNTIFUL, Utah--(BUSINESS WIRE)--Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VyBrate VBR System which is designed for use in both the cervical and thoracolumbar spine for vertebral body replacement surgery. The VyBrate VBR is an innovative device combining the osseointegration properties of the OXPEKK material and the novel OsteoVy lattice structure...

Vy Spine Announces FDA Clearance of 3D Printed LumiVy OsteoVy PEKK Lumbar IBF

BOUNTIFUL, Utah--(BUSINESS WIRE)--Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its LumiVy OsteoVy PEKK Lumbar IBF. The device is indicated for intervertebral body fusion for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis. The LumiVy OsteoVy PEKK...

Vy Spine Announces FDA Clearance for its ClariVy OsteoVy PEKK Cervical IBF

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received U.S. Food and Drug Administration (FDA) clearance for its ClariVy OsteoVy PEKK Cervical IBF, indicated for intervertebral body fusion for use at one level in the cervical spine, from C3 to T1, for the treatment of degenerative disc disease (DDD). The novel ClariVy OsteoVy PEKK Cervical IBF device combines the osseointegration properties of the...
Back to Newsroom